Ustekinumab Dose Optimization in Ulcerative Colitis: Is More Always Better?

dc.contributor.authorChaemsupaphan T.
dc.contributor.authorLimsrivilai J.
dc.contributor.correspondenceChaemsupaphan T.
dc.contributor.otherMahidol University
dc.date.accessioned2025-06-07T18:14:00Z
dc.date.available2025-06-07T18:14:00Z
dc.date.issued2025-01-01
dc.identifier.citationDigestive Diseases and Sciences (2025)
dc.identifier.doi10.1007/s10620-025-09108-6
dc.identifier.eissn15732568
dc.identifier.issn01632116
dc.identifier.scopus2-s2.0-105006886613
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/110555
dc.rights.holderSCOPUS
dc.subjectBiochemistry, Genetics and Molecular Biology
dc.subjectMedicine
dc.titleUstekinumab Dose Optimization in Ulcerative Colitis: Is More Always Better?
dc.typeNote
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105006886613&origin=inward
oaire.citation.titleDigestive Diseases and Sciences
oairecerif.author.affiliationSiriraj Hospital

Files

Collections